Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ)
CNY 5.88
(3.34%)
CNY 5.88
(3.34%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.28 Billion CNY | 47.09% |
| 2022 | 871.27 Million CNY | 0.65% |
| 2021 | 865.65 Million CNY | 18.88% |
| 2020 | 728.15 Million CNY | -37.65% |
| 2019 | 1.16 Billion CNY | -5.59% |
| 2018 | 1.23 Billion CNY | -3.21% |
| 2017 | 1.27 Billion CNY | 5.07% |
| 2016 | 1.21 Billion CNY | 6.2% |
| 2015 | 1.14 Billion CNY | -8.44% |
| 2014 | 1.25 Billion CNY | 11.82% |
| 2013 | 1.11 Billion CNY | 21.18% |
| 2012 | 923.32 Million CNY | 37.61% |
| 2011 | 670.95 Million CNY | 35.31% |
| 2010 | 495.87 Million CNY | 30.29% |
| 2009 | 380.6 Million CNY | 19.77% |
| 2008 | 317.78 Million CNY | 49.67% |
| 2007 | 212.32 Million CNY | 52.87% |
| 2006 | 138.89 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 235.25 Million CNY | -17.19% |
| 2024 Q2 | 284.1 Million CNY | -26.59% |
| 2024 Q1 | 387.01 Million CNY | 5.17% |
| 2023 Q1 | 369.86 Million CNY | 51.96% |
| 2023 Q4 | 367.97 Million CNY | 48.28% |
| 2023 FY | 1.28 Billion CNY | 47.09% |
| 2023 Q3 | 248.16 Million CNY | -16.04% |
| 2023 Q2 | 295.56 Million CNY | -20.09% |
| 2022 Q4 | 243.4 Million CNY | 15.83% |
| 2022 Q1 | 272.46 Million CNY | 17.25% |
| 2022 Q2 | 145.25 Million CNY | -46.69% |
| 2022 Q3 | 210.14 Million CNY | 44.67% |
| 2022 FY | 871.27 Million CNY | 0.65% |
| 2021 FY | 865.65 Million CNY | 18.88% |
| 2021 Q4 | 232.37 Million CNY | 15.68% |
| 2021 Q1 | 274.94 Million CNY | 36.35% |
| 2021 Q3 | 200.87 Million CNY | 27.57% |
| 2021 Q2 | 157.46 Million CNY | -42.73% |
| 2020 Q2 | 147.01 Million CNY | -39.06% |
| 2020 FY | 728.15 Million CNY | -37.65% |
| 2020 Q4 | 201.64 Million CNY | 45.87% |
| 2020 Q3 | 138.23 Million CNY | -5.98% |
| 2020 Q1 | 241.26 Million CNY | -17.72% |
| 2019 FY | 1.16 Billion CNY | -5.59% |
| 2019 Q4 | 293.22 Million CNY | 28.99% |
| 2019 Q3 | 227.31 Million CNY | -28.99% |
| 2019 Q2 | 320.12 Million CNY | -2.15% |
| 2019 Q1 | 327.14 Million CNY | 17.22% |
| 2018 Q3 | 196.9 Million CNY | -38.5% |
| 2018 FY | 1.23 Billion CNY | -3.21% |
| 2018 Q4 | 279.08 Million CNY | 41.74% |
| 2018 Q1 | 440.86 Million CNY | 70.81% |
| 2018 Q2 | 320.17 Million CNY | -27.38% |
| 2017 Q1 | 372.58 Million CNY | 55.08% |
| 2017 Q3 | 259.65 Million CNY | -33.03% |
| 2017 Q4 | 258.1 Million CNY | -0.6% |
| 2017 FY | 1.27 Billion CNY | 5.07% |
| 2017 Q2 | 387.73 Million CNY | 4.07% |
| 2016 Q1 | 351.33 Million CNY | 76.94% |
| 2016 Q3 | 249.69 Million CNY | -33.44% |
| 2016 Q4 | 240.24 Million CNY | -3.78% |
| 2016 FY | 1.21 Billion CNY | 6.2% |
| 2016 Q2 | 375.13 Million CNY | 6.77% |
| 2015 FY | 1.14 Billion CNY | -8.44% |
| 2015 Q4 | 198.56 Million CNY | -7.75% |
| 2015 Q3 | 215.23 Million CNY | -43.15% |
| 2015 Q2 | 378.63 Million CNY | 7.27% |
| 2015 Q1 | 352.98 Million CNY | 17.2% |
| 2014 Q4 | 301.17 Million CNY | 9.03% |
| 2014 Q3 | 276.23 Million CNY | -22.11% |
| 2014 Q2 | 354.65 Million CNY | 11.18% |
| 2014 FY | 1.25 Billion CNY | 11.82% |
| 2014 Q1 | 319 Million CNY | 34.59% |
| 2013 Q1 | 279.19 Million CNY | 35.23% |
| 2013 FY | 1.11 Billion CNY | 21.18% |
| 2013 Q4 | 237.02 Million CNY | -15.85% |
| 2013 Q3 | 281.64 Million CNY | -12.25% |
| 2013 Q2 | 320.98 Million CNY | 14.96% |
| 2012 Q1 | 219.49 Million CNY | 20.16% |
| 2012 Q2 | 253.92 Million CNY | 15.69% |
| 2012 Q3 | 243.44 Million CNY | -4.12% |
| 2012 Q4 | 206.45 Million CNY | -15.19% |
| 2012 FY | 923.32 Million CNY | 37.61% |
| 2011 Q2 | 171.2 Million CNY | 11.13% |
| 2011 FY | 670.95 Million CNY | 35.31% |
| 2011 Q4 | 182.66 Million CNY | 12.03% |
| 2011 Q1 | 154.04 Million CNY | -3.71% |
| 2011 Q3 | 163.04 Million CNY | -4.77% |
| 2010 Q1 | 88.77 Million CNY | -12.2% |
| 2010 Q4 | 159.98 Million CNY | 12.88% |
| 2010 Q3 | 141.73 Million CNY | 34.48% |
| 2010 FY | 495.87 Million CNY | 30.29% |
| 2010 Q2 | 105.38 Million CNY | 18.72% |
| 2009 Q3 | 102.07 Million CNY | 9.19% |
| 2009 Q4 | 101.1 Million CNY | -0.95% |
| 2009 FY | 380.6 Million CNY | 19.77% |
| 2009 Q2 | 93.48 Million CNY | 11.39% |
| 2009 Q1 | 83.92 Million CNY | -7.47% |
| 2008 Q4 | 90.7 Million CNY | 20.29% |
| 2008 FY | 317.78 Million CNY | 49.67% |
| 2008 Q3 | 75.4 Million CNY | 0.0% |
| 2007 FY | 212.32 Million CNY | 52.87% |
| 2006 FY | 138.89 Million CNY | 0.0% |